Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment

MeSH terms

• Animals
• Anti-Allergic Agents / therapeutic use
• Antiprotozoal Agents / administration & dosage
• Antiprotozoal Agents / adverse effects
• Arrhythmias, Cardiac / diagnosis
• Arrhythmias, Cardiac / etiology
• Biopsy
• Drug Administration Routes
• Drug Substitution
• Electrocardiography
• Endemic Diseases*
• Exanthema / chemically induced
• Exanthema / therapy
• Female
• Greece
• Humans
• Hypokalemia* / blood
• Hypokalemia* / chemically induced
• Hypokalemia* / complications
• Hypokalemia* / therapy
• Insect Vectors*
• Italy
• Leishmania infantum* / drug effects
• Leishmania infantum* / isolation & purification
• Leishmaniasis, Visceral* / complications
• Leishmaniasis, Visceral* / diagnosis
• Leishmaniasis, Visceral* / drug therapy
• Leishmaniasis, Visceral* / physiopathology
• Leishmaniasis, Visceral* / transmission
• Meglumine Antimoniate
• Meglumine* / administration & dosage
• Meglumine* / adverse effects
• Middle Aged
• Morocco
• Mouth Mucosa / pathology
• Oral Ulcer* / drug therapy
• Oral Ulcer* / etiology
• Oral Ulcer* / pathology
• Oral Ulcer* / physiopathology
• Organometallic Compounds* / administration & dosage
• Organometallic Compounds* / adverse effects
• Phosphorylcholine / administration & dosage
• Phosphorylcholine / adverse effects
• Phosphorylcholine / analogs & derivatives*
• Potassium / blood
• Potassium / therapeutic use
• Psychodidae*
• Spain
• Travel*
• Treatment Outcome